Home
 /
Papers
 /
Immunology
 /
GM-CSF instructs vertebral emergency myelopoiesis in neuropathic pain
Preprint
Open access
V1
Top 1% · Validated by QED

GM-CSF instructs vertebral emergency myelopoiesis in neuropathic pain

Glauce R. Pigatto, Gabriel V. Lucena-Silva, William A. Gonçalves +34 more
November 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.11.23.690022
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Immunology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By demonstrating that meningeal ILC2-derived GM-CSF remotely instructs vertebral bone marrow emergency myelopoiesis after nerve injury, this work overturns the neurocentric view of neuropathic pain and reveals a druggable meningeal immune axis.

Author perspective

What is the most important insight, discovery, or finding from your paper that you would like other scientists to know?
“

Our study establishes a new paradigm linking meningeal immunity and vertebral bone marrow hematopoiesis in the pathogenesis of neuropathic pain. By identifying meningeal ILC-2-derived GM-CSF as the key instructive signal in this axis, our study offers both a conceptual advance and a potential therapeutic target for chronic pain.

”
Thiago M. Cunha

QED claims analysis

Summary

Peripheral nerve injury induces meningeal ILC2s to produce GM-CSF, which instructs emergency myelopoiesis in the vertebral bone marrow, leading to myeloid cell migration through ossified vertebral channels into the DRG meninges where they promote neuropathic pain hypersensitivity.

See full analysis
Main Claim 1 –

Nerve Injury Induces Local Leukocyte Accumulation in Ipsilateral DRG Meninges

Supporting evidence

  • DRG Meningeal Leukocytes Undergo Broad Reprogramming, Predominantly Myeloid Expansion
Main Claim 2 –

Vertebral Bone Marrow Myeloid Cells Migrate to DRG via Channels

Main Claim 3 –

Nerve Injury Triggers Vertebral Emergency Myelopoiesis Driving Pain Hypersensitivity

Main Claim 4 –

ILC2-Derived GM-CSF Induces Vertebral Myelopoiesis to Promote Neuropathic Pain

Supporting evidence

  • GM-CSF Promotes Myelopoiesis and Pain via CSF2R Signaling

Abstract

Meningeal immune cells have recently emerged as critical modulators of neural function in both physiological and pathological states1,. In particular, immune cells within the meninges surrounding the dorsal root ganglia (DRG) have been implicated in the pathogenesis of neuropathic pain. Yet, the cellular complexity of the meningeal immune landscape and the neuroimmune interactions linking this niche to neuropathic pain remain poorly understood. Here, we show that peripheral nerve injury induces both the recruitment of leukocytes to the DRG meninges and their transcriptional reprogramming across innate (primarily myeloid cells) and adaptive immune compartments. The accumulation of myeloid cells, predominantly neutrophils and classical monocytes, within the DRG meninges originates from local vertebral bone marrow (BM) emergency myelopoiesis, followed by their migration through ossified vertebral channels. Further analysis identified meningeal granulocyte-macrophage colony- stimulating factor (GM-CSF), produced mainly by group 2 innate lymphoid cells (ILC2s), as a key mediator that instructs vertebral BM emergency myelopoiesis after peripheral nerve injury, thereby promoting neuropathic pain. These findings uncover a fundamental process linking meningeal immunity to vertebral BM emergency myelopoiesis in the pathophysiological cascade of neuropathic pain and highlight meningeal GM-CSF as the instructive signal orchestrating this neuroimmune axis.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?